Swedish Growth Companies With High Insider Ownership And 31% ROE

Amid a backdrop of mixed global market performance and heightened trade tensions, Sweden's local market dynamics offer a unique perspective for investors. In such an environment, growth companies with high insider ownership can be particularly compelling, as they often signal strong confidence from those closest to the company's operations and future prospects.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name	Insider Ownership	Earnings Growth
CTT Systems (OM:CTT)	16.9%	24.8%
Biovica International (OM:BIOVIC B)	18.7%	73.8%
Magle Chemoswed Holding (OM:MAGLE)	14.9%	72.2%
Sileon (OM:SILEON)	20.3%	109.3%
KebNi (OM:KEBNI B)	37.8%	90.4%
Yubico (OM:YUBICO)	37.5%	43.8%
BioArctic (OM:BIOA B)	34%	50.9%
Calliditas Therapeutics (OM:CALTX)	11.6%	52.9%
edyoutec (NGM:EDYOU)	14.6%	63.1%
SaveLend Group (OM:YIELD)	23.3%	103.4%

Click here to see the full list of 93 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

BioArctic (OM:BIOA B)

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB (ticker: OM:BIOA B) is a Swedish biopharmaceutical company focused on developing biological drugs for central nervous system disorders, with a market capitalization of approximately SEK 20.67 billion.

Operations: The company generates revenue primarily from its biotechnology segment, totaling SEK 252.21 million.

Insider Ownership: 34%

Return On Equity Forecast: 32% (2027 estimate)

BioArctic, a Swedish biopharma firm, is trading 67.2% below its estimated fair value and shows promising growth indicators with earnings forecasted to grow by 50.87% annually. Despite recent insider activity not indicating substantial buying, the company's return on equity is expected to be robust at 31.7% in three years. Analysts predict a significant price increase of 57.4%. Recent approvals of its Alzheimer’s treatment, Leqembi, in multiple regions including Hong Kong and South Korea highlight its expanding market presence and innovation strength.

• Take a closer look at BioArctic's potential here in our earnings growth report.
• Our valuation report here indicates BioArctic may be undervalued.

Sectra (OM:SECT B)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sectra AB (publ) specializes in medical IT and cybersecurity solutions across Sweden, the UK, the Netherlands, and other European countries, with a market capitalization of approximately SEK 47.13 billion.

Operations: The company generates revenue primarily from its Imaging IT Solutions and Secure Communications segments, with respective earnings of SEK 2.55 billion and SEK 367.35 million.

Insider Ownership: 30.3%

Return On Equity Forecast: 30% (2027 estimate)

Sectra AB, a Swedish medical technology company, has shown robust financial and operational growth. Recently reporting a significant increase in quarterly sales to SEK 914.45 million from SEK 745.26 million the previous year, Sectra also launched innovative cloud-based services and genomic diagnostic solutions that enhance healthcare efficiency and precision medicine. Despite these advances, its annual earnings growth forecast of 19.3% is modest compared to more aggressive market expectations.

• Click here to discover the nuances of Sectra with our detailed analytical future growth report.
• Our expertly prepared valuation report Sectra implies its share price may be too high.

Yubico (OM:YUBICO)

Simply Wall St Growth Rating: ★★★★★★

Overview: Yubico AB specializes in providing authentication solutions for computers, networks, and online services, with a market capitalization of SEK 23.08 billion.

Operations: The company generates SEK 1.93 billion from its Security Software & Services segment.

Insider Ownership: 37.5%

Return On Equity Forecast: 28% (2027 estimate)

Yubico, a Swedish company specializing in secure authentication solutions, recently reported a robust first-quarter with sales rising to SEK 504.4 million and net income increasing to SEK 77.5 million. Despite high insider ownership and substantial buying over the past three months, profit margins have declined year-over-year. The company's revenue and earnings are forecasted to grow significantly, outpacing the Swedish market. Additionally, Yubico continues to innovate with new products like MilSecure Mobile for secure DOD web access and updates to its YubiKey technology.

• Delve into the full analysis future growth report here for a deeper understanding of Yubico.
• Insights from our recent valuation report point to the potential overvaluation of Yubico shares in the market.

Key Takeaways

• Dive into all 93 of the Fast Growing Swedish Companies With High Insider Ownership we have identified here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com